Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion

BioMetals

Volumn 11, Issue 1, 1998, Pages 27-32

  Zhao, Guojing ^a   Stevens Jr , S Edward ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Antibacterial activity; E. coli B; Parameters; Silver ion

Indexed keywords

SILVER; SILVER NITRATE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DRUG SENSITIVITY; ESCHERICHIA COLI; GROWTH INHIBITION; NONHUMAN;

ANTI-INFECTIVE AGENTS, LOCAL; CELL DIVISION; DISINFECTANTS; DRUG RESISTANCE, MICROBIAL; ESCHERICHIA COLI; NEPHELOMETRY AND TURBIDIMETRY; OSMOLAR CONCENTRATION; SILVER NITRATE;

BACTERIA (MICROORGANISMS); ESCHERICHIA; ESCHERICHIA COLI B;

EID: 0031984550     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009253223055     Document Type: Article

References (26)

1. Bailey WR, Scott EG. 1974 Determination of susceptibility of bacteria to antimicrobial agents. In Bailey WR, Scott EG, eds. Diagnostic Microbiology. St Louis: The C.V. Mosby Co; 316-317.
2. Becker RO, Spadaro JA. 1978 Treatment of orthopaedic infections with electrically generated silver ions. J Bone and Joint Surg 60(A), 871-881.
3. Berger TJ, Spadaro JA, Chapin SE, Becker RO. 1976a Electrically generated silver ions: quantitative effects on bacterial and mammalian cells. Antimicrob Agents Chemother 9, 357-358.
4. Berger TJ, Spadaro JA, Bierman R, Chapin SE, Becker RO. 1976b. Antifungal properties of electrically generated metallic ions. Antimicrob Agents Chemother 10, 856-860.
5. Bhagava KB, Shirali GN, Abhyankar VS, Garde KC. 1992 Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate. J Laryngol Otol 106, 699-701.
6. Deitch ED, Marino AA, Gillespie TE, Albright JA. 1983 Silver-nylon: a new antimicrobial agent. Antimicrob Agents Chemother 23, 356-359.
7. Ersek RA, Denton DR. 1988 Cross-linked silver-impregnated skin for burn wound management. J Burn Care Rehabil 9, 476-481.
8. Fifield FW, Kealey D. 1975 Principle and Practice of Analytical Chemistry. London: International Textbook Company Limited.
9. Fox CL, Jr 1968 Silver sulphadiazine: a new topical therapy for Pseudomonas in burns. Arch Surg 96, 184-188.
10. Gilman AG, Goodman LS, Gilman A. 1980 Goodman and Gilman's Pharmacological Basis of Therapeutics, 6th ed. New York: Macmillan Publishing Co.
11. Golubovich VN, Rabotnova IL. 1974 Kinetics of growth inhibition in Candida utilis by silver ions. Microbiol 43, 948-950.
12. Gottschalk G. 1988 Bacterial Metabolism. New York: Springer-Verlag.
13. Grier N. 1977 Silver and its compounds. In N. Grier, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lea & Febiger, 376-387.
14. Griffin PM, Tauxe RV. 1991 The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic Escherichia coli and associated hemolytic uremic syndrome. Epidemiological Review 13, 60-98.
15. Hamilton-Miller JM, Shah S, Smith C. 1993 Silver sulphadiazine: a comprehensive in vitro reassessment. Chemotherapy 39, 405-409.
16. Handwerger S, Tomasz A. 1985 Antibiotic to tolerance among clinical isolates of bacteria. Rev Infect Dis 7, 368-386.
17. Joklik WK, Willett HP, Amos DB, Wilfert CM. 1988 Zinsser Microbiology, 19th edn. Connecticut: Appleton & Lange.
18. Long DM. 1972. Silver nitrate therapy as an adjunct in the treatment of myelomeningocele. J Neurosurg 36, 769-772.
19. MacKeen PC, Person S, Warner SC, Snipes W, Stevens SE, Jr 1987 Silver-coated nylon fiber as an antibacterial agent. Antimicrob Agents Chemother 31, 93-99.
20. Modak SM, Fox CL, Jr 1973 Binding of silver sulfadiazine to the cellular components of Pseudomonas aeruginosa. Biochem Pharmacol 22, 2391-2404.
21. Moing G, Thunus L, Dauphin JF, Depy-Dupont G, Deby C. 1990 Anti-inflammatory properties of a preparation containing low doses of copper, gold and silver. Int J Tissue React 12, 251-262.
22. Odenholt-Tornqvist LE, Lowdin E, Cars O. 1992 Post-antibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin Antimicrob Agents Chemother 36, 1852-1858.
23. Sabath LD, Wheeler N, Laverdiere M, Blazevic D, Wilkinson BJ. 1977 A new type of penicillin resistance of Staphylococcus aureus. Lancet 1, 443-447.
24. Slawson RM, Lee H, Trevors JT. 1990. Bacterial interactions with silver. Biol Metals 3, 151-154.
25. Thibodeau EA, Handelman SL, Marquis RE. 1978 Inhibition and killing of oral bacteria by silver ions generated with low density direct current. J Dent Res 57, 922-926.
26. Zhanel GG, Karlowsky JA, Davidson RJ, Hoban DJ. 1992 Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli. Antimicrob Agents Chemother 36, 1136-1139.